| |
| |
|
| Insider
Information: |
Sheridan William P |
| Relationship: |
Chief Medical Officer |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
37,954 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$245,562 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
37,954 |
|
|
| Total
Value |
$245,562 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Medical Officer |
2022-03-10 |
37,954 |
2009-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,786 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
30,286 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2012-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,869 |
52,199 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
64,656 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2014-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
136,539 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,900 |
103,418 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
50,791 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,702 |
D/D |
(799) |
90,052 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2013-03-01 |
4 |
D |
$1.19 |
$2,129 |
D/D |
(1,789) |
62,867 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2013-01-31 |
4 |
A |
$1.38 |
$4,140 |
D/D |
3,000 |
67,656 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2012-03-02 |
4 |
S |
$4.78 |
$4,570 |
D/D |
(956) |
29,330 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2009-01-30 |
4 |
B |
$1.62 |
$4,845 |
D/D |
3,000 |
3,000 |
2.66 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$5,740 |
D/D |
(1,169) |
22,686 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$8,772 |
D/D |
(1,087) |
1,638 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2010-01-11 |
4 |
OE |
$2.58 |
$10,748 |
D/D |
4,166 |
4,166 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• – – |
2009-12-01 |
4 |
OE |
$2.58 |
$10,751 |
D/D |
4,167 |
4,167 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$13,173 |
D/D |
(2,081) |
88,677 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$17,738 |
D/D |
(1,739) |
95,123 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2013-05-28 |
4 |
OE |
$1.20 |
$19,688 |
D/D |
16,407 |
82,274 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$20,329 |
D/D |
(1,739) |
137,122 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP - CMO |
• • – |
2014-01-01 |
4 |
D |
$7.60 |
$20,786 |
D/D |
(2,735) |
82,539 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$21,476 |
D/D |
(2,081) |
94,326 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$25,871 |
D/D |
(4,628) |
18,058 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-12-30 |
4 |
OE |
$1.42 |
$32,808 |
D/D |
23,104 |
115,622 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$33,258 |
D/D |
(2,735) |
100,683 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
